Jianyin Zhou
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 18, 2025
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.Shao-Ming Wei, Zhen-Xin Zeng, Rong-Jian Pan
|Mar 24, 2025
Correction: Comparison of primary duct closure versus T-tube drainage in laparoscopic common bile duct exploration: a propensity score matching analysis.Xiangmei Chen, Jianming Liu, Pingguo Liu
|Feb 24, 2025
Comparison of primary duct closure versus T-tube drainage in laparoscopic common bile duct exploration: a propensity score matching analysis.Xiangmei Chen, Jianming Liu, Pingguo Liu
|Sep 30, 2024
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study.Zhong-Tai Lin, Shao-Ming Wei, Jun-Yi Wu
|Dec 11, 2023
Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?Jia-Yi Wu, Jun-Yi Wu, De-Yi Liu
|Oct 22, 2021
Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study.Jia-Yi Wu, Zhen-Yu Yin, Yan-Nan Bai
Pageof 2
